You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.


HIV Updates: Implementing Long-Acting Injectables Into Clinical Practice

  • Authors: Laura Beauchamps, MD
  • CME / ABIM MOC / CE Released: 5/9/2022
  • Valid for credit through: 5/9/2023, 11:59 PM EST
Start Activity

Target Audience and Goal Statement

This activity is intended for infectious disease/HIV specialists, primary care physicians, pharmacists, and nurses.

The goal of this activity is that learners will be better able to educate clinicians on how to implement long-acting injectables (LAIs) for HIV into clinical practice, including clinician-patient communication to optimize both patient outcomes and satisfaction.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Practical considerations when implementing the use of LAI therapy into clinical care for people living with HIV (PLWH)
  • Have greater competence related to
    • Identifying patients who would benefit from an LAI antiretroviral (ARV) regimen
  • Demonstrate greater confidence in their ability to
    • Use team-based communication strategies for discussing injectable treatment options for PLWH


Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.


  • Laura Beauchamps, MD

    Assistant Professor of Clinical Medicine
    University of Miami Miller School of Medicine
    Miami, Florida


    Disclosure: Laura Beauchamps, MD, has no relevant financial relationships.


  • Kimberly Storck, PharmD, RPh

    Senior Director, Content Development, Medscape, LLC


    Disclosure: Kimberly Storck, PharmD, RPh, has no relevant financial relationships.

  • Maria Uravich, BSc, ELS

    Senior Medical Education Director, Medscape, LLC


    Disclosure: Maria Uravich, BSc, ELS, has no relevant financial relationships.

Compliance Reviewer/Nurse Planner

  • Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC


    Disclosure: Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP, has no relevant financial relationships.

Accreditation Statements


Interprofessional Continuing Education

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


This activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credit for learning and change.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

    For Nurses

  • Awarded 0.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.25 contact hours are in the area of pharmacology.

    Contact This Provider

    For Pharmacists

  • Medscape designates this continuing education activity for 0.25 contact hour(s) (0.025 CEUs) (Universal Activity Number: JA0007105-0000-22-099-H01-P).

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.


HIV Updates: Implementing Long-Acting Injectables Into Clinical Practice

Authors: Laura Beauchamps, MDFaculty and Disclosures

CME / ABIM MOC / CE Released: 5/9/2022

Valid for credit through: 5/9/2023, 11:59 PM EST


Medscape Clinic Patient info

Patient first and last name: Shane Jefferson

Patient Age: 28 years old

Relevant History: Man who has sex with men (MSM) with a 3-year history of HIV infection; virologically suppressed on an ART regimen of dolutegravir-lamivudine 50-300 mg

Shane is a young professional who is visiting his provider for a routine check-in. He is 28 years old and has been living with HIV for 3 years. He successfully manages his HIV infection by adhering to his ART regimen.



Post-Assessment Survey

What did you learn from this activity? Please proceed to a brief survey.

  • Print